1. Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. (31st December 2022) Authors: Laureano, Raquel S; Sprooten, Jenny; Vanmeerbeerk, Isaure; Borras, Daniel M; Govaerts, Jannes; Naulaerts, Stefan; Berneman, Zwi N; Beuselinck, Benoit; Bol, Kalijn F; Borst, Jannie; Coosemans, an; Datsi, Angeliki; Fučíková, Jitka; Kinget, Lisa; Neyns, Bart; Schreibelt, Gerty; Smits, Evelien; Sorg,... Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. (31st December 2022) Authors: Laureano, Raquel S; Sprooten, Jenny; Vanmeerbeerk, Isaure; Borras, Daniel M; Govaerts, Jannes; Naulaerts, Stefan; Berneman, Zwi N; Beuselinck, Benoit; Bol, Kalijn F; Borst, Jannie; Coosemans, an; Datsi, Angeliki; Fučíková, Jitka; Kinget, Lisa; Neyns, Bart; Schreibelt, Gerty; Smits, Evelien; Sorg,... Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗